MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma.
about
MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MYCN amplification predicts po ...... w metastases of neuroblastoma.
@en
MYCN amplification predicts po ...... w metastases of neuroblastoma.
@nl
type
label
MYCN amplification predicts po ...... w metastases of neuroblastoma.
@en
MYCN amplification predicts po ...... w metastases of neuroblastoma.
@nl
prefLabel
MYCN amplification predicts po ...... w metastases of neuroblastoma.
@en
MYCN amplification predicts po ...... w metastases of neuroblastoma.
@nl
P2093
P2860
P1476
MYCN amplification predicts po ...... w metastases of neuroblastoma.
@en
P2093
Cheng Huang
Shu-Guang Liu
Tian-Yu Xing
Xi-Si Wang
Xiao-Li Ma
Xing-Jun Li
P2860
P2888
P356
10.1186/S12935-017-0412-Z
P577
2017-03-31T00:00:00Z
P6179
1084251186